The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression

Molecular Pharmacology

Volumn 68, Issue 3, 2005, Pages 616-624

  Rothem, Lilah ^a   Berman, Bluma ^a   Stark, Michal ^a   Jansen, Gerrit ^b   Assaraf, Yehuda G ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE;

ANIMAL CELL; ARTICLE; AUTOFLUORESCENCE; BIOSYNTHESIS; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GLYCOSYLATION; IMMUNOFLUORESCENCE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPORTER GENE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; GENETIC MARKERS; GREEN FLUORESCENT PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; RECOMBINANT PROTEINS; SUBCELLULAR FRACTIONS;

EID: 23944490961     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.013540     Document Type: Article

References (40)

1. Assaraf YG and Schimke RT (1987) Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry. Proc Natl Acad Sci USA 84:7154-7158.
2. Bebbington CR, Renner G, Thomson S, King D, Abrams D, and Yarranton GT (1992) High level expression of recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable marker. Biotechnology (NY) 10:169-175.
3. Drori S, Jansen G, Mauritz R, Peters G, and Assaraf YG (2000a) Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. J Biol Chem 275:30855-30863.
4. Drori S, Sprecher H, Shemer G, Jansen G, Goldman ID, and Assaraf YG (2000b) Characterization of a human alternatively spliced truncated reduced folate carrier (RFC) increasing folate accumulation in parental leukemia cells. Eur J Biochem 267:690-702.
5. Ferguson PL and Flintoff WF (1999) Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion. J Biol Chem 274:16269-16278.
6. Freisheim J, Ratnam M, McAlinden TP, Prasad KMR, Williams FE, Westerhof GR, Schornagel JH, and Jansen G (1992) Molecular events in membrane transport of methotrexate in human CCRF-CEM leukemia cells. Adv Enzyme Regul 32:17-31.
7. Fry DW and Besserer JA (1988) Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates. Cancer Res 48:6986-6991.
8. Goldman ID (1971) The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann NY Acad Sci 186:400-422.
9. Gorlick R, Goker E, Trippett T, Waltham M, Banergee D, and Bertino JR (1996) Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335:1041-1048.
10. Guo W, Healey JH, Meyers PA, Ladanyi M, Huvos AG, Bertino JR, and Gorlick R (1999) Mechanisms of methotrexate resistance in osteosarcoma. Clin Cancer Res 5:621-627.
11. Gorlick R, Goker E, Trippett T, Steinberg P, Elisseyef Y, Mazumdar M, Flintoff WF, and Bertino JR (1997) Defective transport is a common mechanism of acquired resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 89:1013-1018.
12. Hartman SC and Mulligan RC (1988) Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc Natl Acad Sci USA 85:8047-8051.
13. Henderson GB and Zevely EM (1981) Anion exchange mechanism for transport of methotrexate in L1210 cells. Biochem Biophys Res Commun 99:163-169.
14. Ifergan I, Meller I, Issakov J, and Assaraf YG (2003) Reduced folate carrier protein expression in osteosarcoma: implications for prediction of tumor chemosensitivity. Cancer 98:1598-1966.
15. Jansen G, Kathmann I, Rademaker BC, Braakhuis BJ, Westerhof GR, Rijksen G, and Schornagel JH (1989) Expression of a folate-binding protein in L1210 cells grown in low folate medium. Cancer Res 49:1959-1963.
16. Jansen G, Mauritz R, Drori S, Sprecher H, Kathmann I, Bunni M, Priest DG, Noordhuis P, Schornagel JH, Pinedo HM, et al. (1998) A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem 273: 30189-30198.
17. Jansen G, Westerhof GR, Jarmuszewski MJA, Kathmann I, Rijksen G, and Schornagel JH (1990) Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier: selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem 265:18272-18277.
18. Johnstone AP and Harfst E (1992) Characterization of the glutamine synthetase amplifiable eukaryotic expression applied to an integral membrane protein-the human thyrotropin receptor. Anal Biochem 207:80-84.
19. Kaufman Y, Drori S, Cole PD, Kamen BA, Sirota J, Ifergan I, Rechavi G, Toren A, Weyl Ben-Arush M, Elhasid R, et al. (2004) Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia. Cancer 100:773-782.
20. Liu XY and Matherly LH (2002) Analysis of membrane topology of the human reduced folate carrier protein by HA epitope insertion and scanning glycosylation insertion mutagenesis. Biochim Biophys Acta 1564:332-342.
21. Matherly LH and Goldman ID (2003) Membrane transport of folates. Vitam Horm 66:403-456.
22. McCarthy EA, Titus SA, Taylor SM, Jackson-Cook C, and Moran RG (2004) A mutation inactivating the mitochondrial inner membrane folate transporter creates a glycine requirement for survival of Chinese hamster cells. J Biol Chem 279:33829-33836.
23. Pao SS, Paulsen IT, and Saier MH Jr (1998) Major facilitator superfamily. Microbiol Mol Rev 62:1-34.
24. Pu H, Cashion LM, Kretschmer PJ, and Liu Z (1998) Rapid establishment of highproducing cell lines using dicistronic vectors with glutamine synthetase as the selection marker. Mol Biotechnol 10:17-25.
25. Rothem L, Ifergan I, Kaufman Y, Priest DG, Jansen G, and Assaraf YG (2002) Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines. Biochem J 367:741-750.
26. Rothem L, Aronheim A, and Assaraf YG (2003) Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells. J Biol Chem 278:8935-8941.
27. Rothem L, Stark M, Kaufman Y, Mayo L, and Assaraf YG (2004a) Reduced folate carrier gene silencing in multiple antifolate-resistant tumor cell lines is due to a simultaneous loss of function of multiple transcription factors but not promoter methylation. J Biol Chem 279:374-384.
28. Rothem L, Stark M, and Assaraf YG (2004b) Impaired CREB-1 phosphorylation in antifolate-resistant cell lines with down-regulation of the reduced folate carrier gene. Mol Pharmacol 66:1536-1543.
29. Schimke RT (1988) Gene amplification in cultured cells. J Biol Chem 263:5989-5992.
30. Stockstad ELR (1990) Historical perspective on key advances in the biochemistry and physiology of folates. In: Folic Acid Metabolism in Health and Disease (Piccianno, M.F., Stockstad, E.L.R., Gregory, J.F. eds), pp. 1-21, Wiley-Liss, New York.
31. Titus SA and Moran RG (2000) Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J Biol Chem 275:36811-36817.
32. Trippett TM, Garcia S, Manova K, Moely R, Cohen-Gould L, Flintoff W, and Bertino JR (2001) Localization of a human reduced folate carrier protein in the mitochondrial as well as the cell membrane of leukemic cells. Cancer Res 61:1941-1947.
33. Wang Y, Zhao R, Russell RG, and Goldman ID (2001) Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis. Biochem Biophys Acta 1513:49-54.
34. Wong SC, Zhang L, Proefke SA, and Matherly LH (1998) Effects of the loss of capacity for N-glycosylation on methotrexate transport activity and cellular localization of the human reduced folate carrier. Biochim Biophys Acta 1375:6-12.
35. Worm J, Kirkin AF, Dzhandzhugazyan KN, and Guldberg P (2001) Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. J Biol Chem 276:39990-40000.
36. Yang R, Sowers R, Mazza B, Healey JH, Huvos A, Grier H, Bernstein M, Beardsley GP, Krailo MD, Devidas M, et al. (2003) Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Clin Cancer Res 9:837-844.
37. Zhao R and Goldman ID (2003) Resistance to antifolates. Oncogene 22:7431-7457.
38. Zhao R, Gao F, Wang Y, Diaz GA, Gelb BD, and Goldman ID (2001a) Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem 276:1114-1118.
39. Zhao R, Russell RG, Wang Y, Liu L, Gao F, Kneitz B, Edelmann W, and Goldman ID (2001b) Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 276:10224-10228.
40. Zou Z and Sun PD (2004) Overexpression of human transforming growth factor-β1 using a recombinant CHO cell expression system. Protein Expr Purif 37:265-272.